Change of Director's Interest Notice
Released
Released
Announcement PDF
Appendix 3Y
Change of Director’s Interest Notice
Appendix 3Y
Rule 3.19A.2
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information
and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01
Amended 01/01/11
Name of entity
Paradigm Biopharmaceuticals Limited
ABN
94 169 346 963
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for
the director for the purposes of section 205G of the Corporations Act.
Name of Director
Matthew James Fry
Date of last notice
05 December 2024
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Direct or indirect interest
Indirect interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Matthew James Fry is the legal and beneficial
owner of the securities in Invia Custodian Pty
Ltd ATF Fry Property Trust.
Date of change
03 December 2024
No. of securities held prior to change
1,419,830 Fully Paid Ordinary Shares
Class
Listed Options
Number acquired
354,958 Options Expiring 11-Feb-2026
Number disposed
Nil
Value/Consideration
N/A
Note: If consideration is non-cash, provide details and estimated
valuation
+ See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y
Change of Director’s Interest Notice
No. of securities held after change
1,419,830 Fully Paid Ordinary Shares
354,958 Options Expiring 11-Feb-2026
Nature of change
Loyalty Options Offer
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan,
participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should
be disclosed in this part.
Detail of contract
Not applicable
Nature of interest
Not applicable
Name of registered holder
(if issued securities)
Not applicable
Date of change
Not applicable
No. and class of securities to which Not applicable
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Not applicable
Interest disposed
Not applicable
Value/Consideration
Not applicable
Interest after change
Not applicable
Note: If consideration is non-cash, provide details
and an estimated valuation
Part 3 – +Closed period
Were the interests in the securities or contracts detailed No
above traded during a +closed period where prior written
clearance was required?
If so, was prior written clearance provided to allow the trade Not applicable
to proceed during this period?
If prior written clearance was provided, on what date was this Not applicable
provided?
+ See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Share your feedback
Discover